Avatrombopag, sold under the brand name Doptelet, is a medication used to treat thrombocytopenia (low platelet counts) in adults with chronic liver disease who are scheduled to undergo a planned medical or dental procedure. It is also indicated for adults with chronic immune thrombocytopenia (ITP) who have had an inadequate response to previous treatments. Avatrombopag works by stimulating the production of platelets in the bone marrow, helping to increase platelet levels in the blood, thus reducing the risk of excessive bleeding during procedures.
Parent: Avatrombopag
Parent: Avatrombopag
Parent: Avatrombopag
Parent: Avatrombopag/ Avatrombopag Maleate
Parent: Avatrombopag
Parent: Avatrombopag
Parent: Avatrombopag
Parent: Avatrombopag
During the production and storage of avatrombopag, impurities may form, which must be carefully monitored to ensure the medication’s safety and efficacy. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) provide strict guidelines on allowable impurity levels to ensure the drug is safe for patient use.
Avatrombopag generally begins to take effect within 5 to 8 days after starting the treatment. It is typically prescribed before a planned medical or dental procedure to increase platelet levels and reduce the risk of bleeding.
While avatrombopag is safe for most patients when used as prescribed, it can cause side effects such as headache, fatigue, and nausea. In some cases, it may increase the risk of blood clots, particularly in patients with other risk factors for thrombosis. It is important to use avatrombopag under medical supervision.
Avatrombopag is taken orally, usually once daily for 5 days prior to a scheduled medical or dental procedure for patients with chronic liver disease. For those with immune thrombocytopenia (ITP), it is taken as prescribed by the healthcare provider based on platelet counts. Avatrombopag should be taken with food, and patients should follow the dosing instructions closely.
Fatigue is a common side effect of Doptelet (avatrombopag), along with symptoms like headache, nausea, and fever. If fatigue or other side effects become bothersome, patients should consult their doctor.
